Celso Acevedo, MD
Clinical Cardiac Electrophysiology · Ocala, FLNPI 1851390017
Payments from drug & device makers
Across 642 payments — averaging $220.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$79K
- Impulse Dynamics (USA) Inc.$15K
- Integer Holdings Corporation$14K
- Cardiofocus, Inc.$10K
- Abbott$8K
- Boston Scientific$4K
- plus $12K from 28 others
What the payments were for
- Consulting fees$20,33315%
- Speaking & faculty fees$81,70059%
- Travel & lodging$14,91711%
- Food & beverage$22,22816%
- Education$510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 106 | $78,866 |
| Impulse Dynamics (USA) Inc. | 42 | $15,127 |
| Integer Holdings Corporation | 14 | $14,170 |
| Cardiofocus, Inc. | 39 | $9,858 |
| Abbott | 80 | $7,512 |
| Boston Scientific | 68 | $4,325 |
| Biosense Webster, Inc. | 145 | $3,852 |
| Altathera Pharmaceuticals LLC | 3 | $2,089 |
| Medtronic(2 entities) | 29 | $1,680 |
| Cardiva Medical, Inc. | 19 | $1,029 |
| E.r. Squibb & Sons, L.L.C. | 15 | $549 |
| Biotronik Inc. | 7 | $332 |
| Philips North America LLC | 5 | $227 |
| Kestra Medical Technology Services, Inc. | 12 | $216 |
| Angiodynamics, Inc. | 11 | $207 |
| Abiomed | 5 | $179 |
| GE HealthCare | 2 | $173 |
| Cook Medical LLC | 5 | $170 |
| Pfizer | 8 | $156 |
| ZOLL Respicardia, Inc. | 1 | $138 |
| Cvrx, Inc. | 1 | $127 |
| Edwards Lifesciences | 3 | $88 |
| Neuros Medical, Inc. | 1 | $74 |
| Atricure, Inc. | 2 | $59 |
| Elutia, Inc. | 4 | $57 |
| Inari Medical, Inc. | 2 | $56 |
| Lexicon Pharmaceuticals, Inc. | 3 | $56 |
| Merck | 3 | $52 |
| Johnson & Johnson | 1 | $32 |
| Scpharmaceuticals Inc. | 1 | $28 |
| Bardy Diagnostics, Inc. | 2 | $27 |
| Novartis | 1 | $21 |
| Convatec Inc. | 1 | $16 |
| Penumbra, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$77,850
- OPTIMIZER$27,692
- HeartLight System$7,269
- BIS/BIS Lead Adaptors & Extensions Unipolar and Bifurcated Lead Adaptors Destino$5,200
- Destino Twist$3,380
- AVEIR$2,506
- Sotalol Hydrochloride$2,079
- Adelante, Adelante S Lite, Adelante, SII, Adelante S2/S2S$1,820
- GENERAL - THERAPIES$1,258
- Carto 3$1,093
- Breezeway II$1,040
- Guidestar anchor ring$650
- NUVISION ICE CATHETER$544
- Port Plugs$520
- ENSITE PRECISION$443
- Reveal LINQ$333
- Micra$326
- WATCHMAN FLX$297
- Farapulse$282
- OPTIMIZER SMART SYSTEM$281
How this compares
$141,561 in reported general payments places this provider in the 75th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 74 | $72,346 |
| MultaqDronedarone Hcl | 26 | $25,870 |
| Diltiazem 12hr ErDiltiazem Hcl | 23 | $6,758 |
| Flecainide Acetate | 123 | $5,185 |
| SotalolSotalol Hcl | 250 | $4,847 |
| Ranolazine ErRanolazine | 30 | $2,637 |
| Diltiazem Hcl | 114 | $2,195 |
| Mexiletine Hcl | 20 | $1,930 |
| Amiodarone Hcl | 75 | $1,303 |
| ClopidogrelClopidogrel Bisulfate | 86 | $853 |
| Metoprolol Succinate | 22 | $357 |
| Celecoxib | 17 | $351 |
| Fludrocortisone Acetate | 20 | $324 |
| Metoprolol Tartrate | 40 | $266 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $156 | $72,34674 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Ocala
- Jose Osorio FilhoMiami$16.4M
- Saumil OzaJacksonville$4.1M
- Usman SiddiquiWinter Park$3.6M
- David KenigsbergFort Lauderdale$1.3M
- Venkata SagiJacksonville$1.2M
- Raul WeissMiami Beach$1.1M
- Robert FishelAtlantis$1.1M
- Naushad ShaikKissimmee$1.1M
- Neal KaveshLakeland$967K
- Antonio MorettaSarasota$891K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.